A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol

T Alam; D Ahmed; T Ahmed; MJ Chisti; MW Rahman; AK Asthana; PK Bansal; A Chouhan; S Deb; P Dhingra; U Dhingra; A Dutta; VK Jaiswal; J Kumar; A Pandey; S Sazawal; AK Sharma; C McGrath; C Nyabinda; M Okello; PB Pavlinac; B Singa; JL Walson; N Bar-Zeev; Q Dube; B Freyne; C Ndamala; L Ndeketa; H Badji; JP Booth; F Coulibaly; F Haidara; K Kotloff; D Malle; A Mehta; S Sow; M Tapia; S Tennant; A Hotwani; F Kabir; F Qamar; S Qureshi; S Shakoor; R Thobani; MT Yousufzai; M Bakari; C Duggan; U Kibwana; R Kisenge; K Manji; P Ashorn

doi:10.1186/s13063-019-3829-y

A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol

T Alam, D Ahmed, T Ahmed, MJ Chisti, MW Rahman, AK Asthana, PK Bansal, A Chouhan, S Deb, P Dhingra, U Dhingra, A Dutta, VK Jaiswal, J Kumar, A Pandey, S Sazawal, AK Sharma, C McGrath, C Nyabinda, M OkelloPB Pavlinac, B Singa, JL Walson, N Bar-Zeev, Q Dube, B Freyne, C Ndamala, L Ndeketa, H Badji, JP Booth, F Coulibaly, F Haidara, K Kotloff, D Malle, A Mehta, S Sow, M Tapia, S Tennant, A Hotwani, F Kabir, F Qamar, S Qureshi, S Shakoor, R Thobani, MT Yousufzai, M Bakari, C Duggan, U Kibwana, R Kisenge, K Manji, P Ashorn

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	Englanti
Artikkeli	71
Sivut	71
Julkaisu	Trials
Vuosikerta	21
Numero	1
DOI - pysyväislinkit	https://doi.org/10.1186/s13063-019-3829-y
Tila	Julkaistu - 2020
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Tutkimusalat

Antibiotics
Azithromycin
Growth
Mortality
Paediatric diarrhoea
Randomised

Julkaisufoorumi-taso

Jufo-taso 1

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

Pääsy asiakirjaan

10.1186/s13063-019-3829-y

http://urn.fi/urn:nbn:fi:tuni-202003242839

Siteeraa tätä

Alam, T., Ahmed, D., Ahmed, T., Chisti, MJ., Rahman, MW., Asthana, AK., Bansal, PK., Chouhan, A., Deb, S., Dhingra, P., Dhingra, U., Dutta, A., Jaiswal, VK., Kumar, J., Pandey, A., Sazawal, S., Sharma, AK., McGrath, C., Nyabinda, C., ... Ashorn, P. (2020). A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol. Trials, 21(1), 71. Artikkeli 71. https://doi.org/10.1186/s13063-019-3829-y

@article{16faba0ffc054f9cb41f061d05d8166a,

title = "A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol",

keywords = "Antibiotics, Azithromycin, Growth, Mortality, Paediatric diarrhoea, Randomised, Antibiotics, Azithromycin, Growth, Mortality, Paediatric diarrhoea, Randomised",

author = "T Alam and D Ahmed and T Ahmed and MJ Chisti and MW Rahman and AK Asthana and PK Bansal and A Chouhan and S Deb and P Dhingra and U Dhingra and A Dutta and VK Jaiswal and J Kumar and A Pandey and S Sazawal and AK Sharma and C McGrath and C Nyabinda and M Okello and PB Pavlinac and B Singa and JL Walson and N Bar-Zeev and Q Dube and B Freyne and C Ndamala and L Ndeketa and H Badji and JP Booth and F Coulibaly and F Haidara and K Kotloff and D Malle and A Mehta and S Sow and M Tapia and S Tennant and A Hotwani and F Kabir and F Qamar and S Qureshi and S Shakoor and R Thobani and MT Yousufzai and M Bakari and C Duggan and U Kibwana and R Kisenge and K Manji and P Ashorn",

year = "2020",

doi = "10.1186/s13063-019-3829-y",

language = "English",

volume = "21",

pages = "71",

number = "1",

}

Alam, T, Ahmed, D, Ahmed, T, Chisti, MJ, Rahman, MW, Asthana, AK, Bansal, PK, Chouhan, A, Deb, S, Dhingra, P, Dhingra, U, Dutta, A, Jaiswal, VK, Kumar, J, Pandey, A, Sazawal, S, Sharma, AK, McGrath, C, Nyabinda, C, Okello, M, Pavlinac, PB, Singa, B, Walson, JL, Bar-Zeev, N, Dube, Q, Freyne, B, Ndamala, C, Ndeketa, L, Badji, H, Booth, JP, Coulibaly, F, Haidara, F, Kotloff, K, Malle, D, Mehta, A, Sow, S, Tapia, M, Tennant, S, Hotwani, A, Kabir, F, Qamar, F, Qureshi, S, Shakoor, S, Thobani, R, Yousufzai, MT, Bakari, M, Duggan, C, Kibwana, U, Kisenge, R, Manji, K & Ashorn, P 2020, 'A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol', Trials, Vuosikerta 21, Nro 1, 71, Sivut 71. https://doi.org/10.1186/s13063-019-3829-y

A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol. / Alam, T; Ahmed, D; Ahmed, T et al.
julkaisussa: Trials, Vuosikerta 21, Nro 1, 71, 2020, s. 71.

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol

AU - Alam, T

AU - Ahmed, D

AU - Ahmed, T

AU - Chisti, MJ

AU - Rahman, MW

AU - Asthana, AK

AU - Bansal, PK

AU - Chouhan, A

AU - Deb, S

AU - Dhingra, P

AU - Dhingra, U

AU - Dutta, A

AU - Jaiswal, VK

AU - Kumar, J

AU - Pandey, A

AU - Sazawal, S

AU - Sharma, AK

AU - McGrath, C

AU - Nyabinda, C

AU - Okello, M

AU - Pavlinac, PB

AU - Singa, B

AU - Walson, JL

AU - Bar-Zeev, N

AU - Dube, Q

AU - Freyne, B

AU - Ndamala, C

AU - Ndeketa, L

AU - Badji, H

AU - Booth, JP

AU - Coulibaly, F

AU - Haidara, F

AU - Kotloff, K

AU - Malle, D

AU - Mehta, A

AU - Sow, S

AU - Tapia, M

AU - Tennant, S

AU - Hotwani, A

AU - Kabir, F

AU - Qamar, F

AU - Qureshi, S

AU - Shakoor, S

AU - Thobani, R

AU - Yousufzai, MT

AU - Bakari, M

AU - Duggan, C

AU - Kibwana, U

AU - Kisenge, R

AU - Manji, K

AU - Ashorn, P

PY - 2020

Y1 - 2020

KW - Antibiotics

KW - Azithromycin

KW - Growth

KW - Mortality

KW - Paediatric diarrhoea

KW - Randomised

KW - Antibiotics

KW - Azithromycin

KW - Growth

KW - Mortality

KW - Paediatric diarrhoea

KW - Randomised

U2 - 10.1186/s13063-019-3829-y

DO - 10.1186/s13063-019-3829-y

M3 - Article

SN - 1745-6215

VL - 21

SP - 71

JO - Trials

JF - Trials

IS - 1

M1 - 71

ER -